Our in vitro study also indicated that AREG significantly enhanced the growth of cetuximab-sensitive RAS/BRAF wild-type colorectal cancer cell lines with increased phosphorylation of AKT and ERK1/2. The gene discussed is AREG; the disease is colorectal cancer.